Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05089903 · ClinicalTrials.gov registry record · NA
Breast Cancer Outreach Among Primary Care Patients
A NA study, sponsored by Abramson Cancer Center at Penn Medicine.
- Completed
- Registry status
- NA
- Development phase
- 24,680
- Enrollment target
NCT05089903 is a NA study that has completed, run by Abramson Cancer Center at Penn Medicine. The registered enrollment target is 24,680 participants.
The verdict
NCT05089903, a NA study, has completed, sponsored by Abramson Cancer Center at Penn Medicine.
- COMPLETED
- Registry status
- NA
- Development phase
- 24,680 participants
- Enrollment target
Study Summary
This project aims to evaluate different approaches to increase breast cancer screening among primary care patients at Penn Medicine through a centralized screening outreach program. In a pragmatic trial, the investigators will evaluate different approaches to increase completion of screening among eligible patients, including ordering mammograms in bulk prior to outreach, sending personalized text reminders, and endorsing of the communication by the primary care provider.
Interventions
- BEHAVIORAL Texting
- BEHAVIORAL Bulk Order
- BEHAVIORAL Clinician Endorsement
- BEHAVIORAL No Bulk Order
- BEHAVIORAL Standard Endorsement
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24,680 participants |
| Start Date | 2021-10-25 |
| Est. Completion | 2022-04-25 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05089903
The ClinicalTrials.gov registry entry for NCT05089903 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 24,680 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abramson Cancer Center at Penn Medicine, which has 402 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Texting is the first listed.
NCT05089903 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05089903 about?
NCT05089903 is a clinical study titled "Breast Cancer Outreach Among Primary Care Patients". This project aims to evaluate different approaches to increase breast cancer screening among primary care patients at Penn Medicine through a centralized screening outreach program. In a pragmatic trial, the investigators will evaluate different approaches to increase completion of screening among e...
What is the current status of trial NCT05089903?
This trial is currently completed. It is a NA study. The enrollment target is 24,680 participants. The study started on 2021-10-25. Estimated completion is 2022-04-25.
What interventions are being tested in trial NCT05089903?
The interventions under investigation include: Texting (BEHAVIORAL), Bulk Order (BEHAVIORAL), Clinician Endorsement (BEHAVIORAL), No Bulk Order (BEHAVIORAL), Standard Endorsement (BEHAVIORAL).
Who is sponsoring clinical trial NCT05089903?
This trial is sponsored by Abramson Cancer Center at Penn Medicine, which has 402 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.